Katie L. Stewart
Atomic Details of the Interactions of Glycosaminoglycans with Amyloid-beta Fibrils
Stewart, Katie L.; Hughes, Eleri; Yates, Edwin A.; Akien, Geoffrey R.; Huang, Teng-Yi; Andrade De Lima, M; Rudd, Timothy R.; Guerrini, Marco; Hung, Shang-Cheng; Radford, Sheena E.; Middleton, David A.
Authors
Eleri Hughes
Edwin A. Yates
Geoffrey R. Akien
Teng-Yi Huang
Marcelo Andrade De Lima m.andrade.de.lima@keele.ac.uk
Timothy R. Rudd
Marco Guerrini
Shang-Cheng Hung
Sheena E. Radford
David A. Middleton
Abstract
The amyloid plaques associated with Alzheimer’s disease (AD) comprise fibrillar amyloid-ß (Aß) peptides as well as non-protein factors including glycosaminoglycan (GAG) polysaccharides. GAGs affect the kinetics and pathway of Aß self-assembly and can impede fibril clearance; thus, they may be accessory molecules in AD. Here we report the first high-resolution details of GAG–Aß fibril interactions from the perspective of the saccharide. Binding analysis indicated that the GAG proxy heparin has a remarkably high affinity for Aß fibrils with 3-fold cross-sectional symmetry (3Q). Chemical synthesis of a uniformly 13C-labeled octasaccharide heparin analogue enabled magic-angle spinning solid-state NMR of the GAG bound to 3Q fibrils, and measurements of dynamics revealed a tight complex in which all saccharide residues are restrained without undergoing substantial conformational changes. Intramolecular 13C–15N dipolar dephasing is consistent with close (<5 Å) contact between GAG anomeric position(s) and one or more histidine residues in the fibrils. These data provide a detailed model for the interaction between 3Q-seeded Aß40 fibrils and a major non-protein component of AD plaques, and they reveal that GAG–amyloid interactions display a range of affinities that critically depend on the precise details of the fibril architecture.
Citation
Stewart, K. L., Hughes, E., Yates, E. A., Akien, G. R., Huang, T.-Y., Andrade De Lima, M., Rudd, T. R., Guerrini, M., Hung, S.-C., Radford, S. E., & Middleton, D. A. (2016). Atomic Details of the Interactions of Glycosaminoglycans with Amyloid-beta Fibrils. Journal of the American Chemical Society, 138(27), 8328-8331. https://doi.org/10.1021/jacs.6b02816
Journal Article Type | Article |
---|---|
Acceptance Date | Mar 17, 2016 |
Publication Date | Jul 13, 2016 |
Publicly Available Date | May 26, 2023 |
Journal | JOURNAL OF THE AMERICAN CHEMICAL SOCIETY |
Print ISSN | 0002-7863 |
Electronic ISSN | 1520-5126 |
Publisher | American Chemical Society |
Volume | 138 |
Issue | 27 |
Pages | 8328-8331 |
DOI | https://doi.org/10.1021/jacs.6b02816 |
Public URL | https://keele-repository.worktribe.com/output/413637 |
Publisher URL | https://pubs.acs.org/doi/abs/10.1021/jacs.6b02816 |
Files
M Lima - Atomic details of the interactions of glycisaminoglycans with amyloid-beta fibrils.pdf
(1.5 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Synthesis of 4-thio-d-glucopyranose and interconversion to 4-thio-d-glucofuranose.
(2023)
Journal Article
Analysis of protein-heparin interactions using a portable SPR instrument
(2022)
Journal Article
New anti-angiogenic compound based on chemically modified heparin
(2022)
Journal Article
Neuroprotective effect of heparin Trisulfated disaccharide on ischemic stroke
(2021)
Journal Article